SMILEDIRECTCLUB INC (SDC)

US83192H1068 - Common Stock

0.075  -0.09 (-53.45%)

After market: 0.065 -0.01 (-13.33%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SDC. SDC was compared to 195 industry peers in the Health Care Equipment & Supplies industry. SDC has a bad profitability rating. Also its financial health evaluation is rather negative. SDC is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

SDC had negative earnings in the past year.
SDC had a negative operating cash flow in the past year.
SDC had negative earnings in each of the past 5 years.
In the past 5 years SDC always reported negative operating cash flow.

1.2 Ratios

SDC has a Return On Assets (-16.58%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -95.61%, SDC is doing worse than 69.80% of the companies in the same industry.
Industry RankSector Rank
ROA -16.58%
ROE -95.61%
ROIC N/A
ROA(3y)-12.07%
ROA(5y)-12.52%
ROE(3y)-54.24%
ROE(5y)-44.43%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of SDC (69.27%) is better than 79.70% of its industry peers.
In the last couple of years the Gross Margin of SDC has grown nicely.
The Profit Margin and Operating Margin are not available for SDC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.96%
GM growth 5Y4.43%

1

2. Health

2.1 Basic Checks

SDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
SDC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SDC has more shares outstanding
Compared to 1 year ago, SDC has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.45, we must say that SDC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SDC (-1.45) is worse than 60.40% of its industry peers.
A Debt/Equity ratio of 9.98 is on the high side and indicates that SDC has dependencies on debt financing.
SDC has a worse Debt to Equity ratio (9.98) than 89.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 9.98
Debt/FCF N/A
Altman-Z -1.45
ROIC/WACCN/A
WACC1.9%

2.3 Liquidity

SDC has a Current Ratio of 1.90. This is a normal value and indicates that SDC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.90, SDC is doing worse than 74.75% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that SDC should not have too much problems paying its short term obligations.
The Quick ratio of SDC (1.58) is worse than 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.58

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.62% over the past year.
The Revenue for SDC has decreased by -23.37% in the past year. This is quite bad
SDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.38% yearly.
EPS 1Y (TTM)22.62%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q23.53%
Revenue 1Y (TTM)-23.37%
Revenue growth 3Y-14.4%
Revenue growth 5Y26.38%
Revenue growth Q2Q-19.08%

3.2 Future

Based on estimates for the next years, SDC will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.80% on average per year.
SDC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.71% yearly.
EPS Next Y39.2%
EPS Next 2Y22.38%
EPS Next 3Y17.81%
EPS Next 5Y13.8%
Revenue Next Year-7.02%
Revenue Next 2Y0.75%
Revenue Next 3Y7.54%
Revenue Next 5Y5.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

SDC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SDC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SDC's earnings are expected to grow with 17.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.38%
EPS Next 3Y17.81%

0

5. Dividend

5.1 Amount

SDC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SMILEDIRECTCLUB INC

NASDAQ:SDC (10/3/2023, 7:22:02 PM)

After market: 0.065 -0.01 (-13.33%)

0.075

-0.09 (-53.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap30.20M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.58%
ROE -95.61%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 69.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 9.98
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.9
Quick Ratio 1.58
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)22.62%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y39.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.37%
Revenue growth 3Y-14.4%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y